PRMT5 and CDK4/6 inhibition result in distinctive patterns of alternative splicing in melanoma. Chan LH, Wang P, Abuhammad S, Lim LRJ, et al. PLoS One 2023;18:e0292278.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chan LH, Wang P, Abuhammad S, Lim LRJ, et al. PRMT5 and CDK4/6 inhibition result in distinctive patterns of alternative splicing in melanoma. PLoS One 2023;18:e0292278.
PMID: 37917641